PT  - JOURNAL ARTICLE
AU  - Shiferaw, Desalegn
AU  - Melaku, Chara
AU  - Assefa, Lamessa
AU  - Kinati, Tadele
TI  - Assessment of Willingness to Receive COVID-19 Vaccine and Associated Factors among Teachers in Dambi Dollo Town, Qellem Wallaga Zone, Oromia Regional State, Ethiopia: Institution based cross sectional study
AID  - 10.1101/2023.01.17.23284660
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.01.17.23284660
4099  - http://medrxiv.org/content/early/2023/01/18/2023.01.17.23284660.short
4100  - http://medrxiv.org/content/early/2023/01/18/2023.01.17.23284660.full
AB  - Background COVID-19 devastated the routine life of all human kind since its discovery in Wuhan, China in 2019 and caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infections. Vaccination is an effective means for controlling the communicability of the disease and every effort has to be done to increase the proportion of vaccinated people against COVID-19.Objective The main objective of this study was to assess the willingness of teachers to receive COVID-19 vaccine and its associated factors in dambi dollo town, 2022.Methods School based cross sectional study design was applied. The data were collected self-administered questionnaire and analysed by SPSS version 23.0. Variables which showed association with dependent variable in the bivariate analyses at 0.25 were entered into multiple stepwise logistic regression model. P-Value 0.05 was considered statistically significant in this study. Adjusted Odds ratios together with corresponding 95% confidence intervals was used to interpret the findings.Results About 92% of the teachers in dambi dollo town have heard covid-19 vaccine and 67.2% of them know that the vaccine can prevent the COVID-19 disease. On the other hand 51 %(95%CI: 44.8, 57.2) of the respondents had good knowledge about COVID-19 vaccine. From the total 247 participants who have responded to our inquiry on their willing to receive the COVID-19 vaccine, 68.4% (95%CI: 62.5, 74.3) of them were willing to receive the vaccine immediately while the remaining were either not willing or not ready at the time of data collection. Those participants having good knowledge of the vaccine were about six times more willing to get vaccinated, (AOR=5.85, 95%CI: 2.74, 12.47) in comparison with those having poor knowledge of the vaccine.Conclusion In conclusion, the level of willingness to receive the COVID-19 Vaccine was 68.4% and relatively low in the current study population and participants’ religion and knowledge status are the two variables significantly associated with willingness to receive the vaccine.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding Statementthis study is funded by Dambi Dollo University. NO, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the ethical clearance for this study was obtained from Dambi Dollo UNiversuty research and innovation directorate through evaluation by a committee established for this issue.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesadditional files will be provided by the authors upon request